Metraipolis › archive › dc_2a3c67eff81f
Evaluation of the Therapeutic Efficacy of the Newly Formulated Drug "Novostron" as an Experimental Basis for Clinical Trials — Europe PMC PMID:40893233
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40893233
- DOI
- 10.1021/acsomega.4c11017
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T16:40:51.919Z
- SHA-256 of the archived text
43828d4ab63399ac4ab10e42d4a03b52105e6110b54c6b31ee8d9ff659d85a5c- Stable URL of this page
https://metraipolis.com/documento/dc_2a3c67eff81f
How to cite
Evaluation of the Therapeutic Efficacy of the Newly Formulated Drug "Novostron" as an Experimental Basis for Clinical Trials — Europe PMC PMID:40893233 — Europe PMC (en), https://europepmc.org/article/MED/40893233 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2a3c67eff81f (Metraipolis archive dc_2a3c67eff81f, sha256 43828d4ab63399ac4ab10e42d4a03b52105e6110b54c6b31ee8d9ff659d85a5c)
BibTeX
@misc{dc2a3c67eff81f,
title = {Evaluation of the Therapeutic Efficacy of the Newly Formulated Drug "Novostron" as an Experimental Basis for Clinical Trials — Europe PMC PMID:40893233},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40893233},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2a3c67eff81f; sha256 43828d4ab63399ac4ab10e42d4a03b52105e6110b54c6b31ee8d9ff659d85a5c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40893233. Agents can read the archived copy with the MCP tool read_document.